KAREN MICHELLE RUDO MD
Prescription History 1982921110
Ophthalmology in Milford, DE

Active since April 28, 2010PECOS EnrolledAccepts Medicare Assignment
81.36/100
CMS Quality Rating
612 N DUPONT BLVD, MILFORD, DE 19963(302) 503-7421 Get Directions

NPPES record last updated: March 16, 2022. Verified against the NPPES registry weekly; last sync: August 02, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for KAREN MICHELLE RUDO MD, an active Ophthalmology specialist practicing in Milford, DE. Our medical registry currently tracks 12 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 429 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 126 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

12
Medications
429
Total Claims
882
30-Day Fills
Latanoprost
Most Prescribed · 126 claims
View details
12 medications · 2023 Medicare Part D
Medicare Part D medications prescribed by KAREN MICHELLE RUDO MD in 2023, with prescription volumes, average cost per fill, and DE state comparisons
Medication Prescriptions (2023)Rx (2023) Avg Cost per FillCost / Fill Vs. Other DE PrescribersVs. DE Avg

About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾

It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA.

In 2023, this provider wrote 126 Medicare prescriptions for Latanoprost, about the same volume as the typical Delaware prescriber of this medication (130). Medicare paid an average of $24.05 per fill, versus $22.14 statewide.

How often this provider prescribes it

This provider
126
DE average
130.0

This provider's prescribing volume for this medication is in line with the average DE prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$24.05
DE average
$22.14

Gross Part D cost per fill; not the patient's out-of-pocket price.

318
30-Day Fills
standardized to 30-day supplies
9,400
Days of Medication
total across all patients in 2023

About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾

Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors.

In 2023, this provider wrote 48 Medicare prescriptions for Dorzolamide-Timolol, about 68% of the volume of the typical Delaware prescriber of this medication (71). Medicare paid an average of $36.68 per fill, versus $29.24 statewide.

How often this provider prescribes it

This provider
48
DE average
71.0

This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$36.68
DE average
$29.24

Gross Part D cost per fill; not the patient's out-of-pocket price.

109.8
30-Day Fills
standardized to 30-day supplies
3,283
Days of Medication
total across all patients in 2023

About Neomycin-Polymyxin-Dexameth: This medication is used to treat conditions involving swelling (inflammation) of the eyes and to treat or prevent bacterial eye infections. Show more ▾

This product contains neomycin and polymyxin, antibiotics that work by stopping the growth of bacteria. It also contains dexamethasone, an anti-inflammatory corticosteroid that works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections and may worsen them (such as infections caused by viruses, fungi, mycobacteria). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.

In 2023, this provider wrote 44 Medicare prescriptions for Neomycin-Polymyxin-Dexameth, about 1.3 times the volume of the typical Delaware prescriber of this medication (33). Medicare paid an average of $13.33 per fill, versus $13.26 statewide.

How often this provider prescribes it

This provider
44
DE average
33.0

This provider prescribes this medication more often than the average DE prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$13.33
DE average
$13.26

Gross Part D cost per fill; not the patient's out-of-pocket price.

45.6
30-Day Fills
standardized to 30-day supplies
1,073
Days of Medication
total across all patients in 2023

About Doxycycline Hyclate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾

This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity.

In 2023, this provider wrote 32 Medicare prescriptions for Doxycycline Hyclate, about the same volume as the typical Delaware prescriber of this medication (28). Medicare paid an average of $58.32 per fill, versus $25.70 statewide.

How often this provider prescribes it

This provider
32
DE average
28.0

This provider's prescribing volume for this medication is in line with the average DE prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$58.32
DE average
$25.70

Gross Part D cost per fill; not the patient's out-of-pocket price.

90
30-Day Fills
standardized to 30-day supplies
2,680
Days of Medication
total across all patients in 2023

About Moxifloxacin: This medication is a quinolone antibiotic used for eye infections. Show more ▾

A fluoroquinolone that acts as an inhibitor of DNA TOPOISOMERASE II and is used as a broad-spectrum antibacterial agent.

In 2023, this provider wrote 31 Medicare prescriptions for Moxifloxacin, about a third of the volume of the typical Delaware prescriber of this medication (84). Medicare paid an average of $35.88 per fill, versus $33.74 statewide.

How often this provider prescribes it

This provider
31
DE average
84.0

This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$35.88
DE average
$33.74

Gross Part D cost per fill; not the patient's out-of-pocket price.

31
30-Day Fills
standardized to 30-day supplies
566
Days of Medication
total across all patients in 2023

About Diclofenac Sodium: See also Warning section. Show more ▾

This medication is used to relieve joint pain from arthritis. Diclofenac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.

In 2023, this provider wrote 29 Medicare prescriptions for Diclofenac Sodium, about the same volume as the typical Delaware prescriber of this medication (31). Medicare paid an average of $16.29 per fill, versus $38.74 statewide.

How often this provider prescribes it

This provider
29
DE average
31.0

This provider's prescribing volume for this medication is in line with the average DE prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$16.29
DE average
$38.74

This provider's average cost per fill is below the DE average for this medication.

31.7
30-Day Fills
standardized to 30-day supplies
867
Days of Medication
total across all patients in 2023

About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾

Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids.

In 2023, this provider wrote 27 Medicare prescriptions for Prednisolone Acetate, about a third of the volume of the typical Delaware prescriber of this medication (92). Medicare paid an average of $77.96 per fill, versus $50.65 statewide.

How often this provider prescribes it

This provider
27
DE average
92.0

This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$77.96
DE average
$50.65

Gross Part D cost per fill; not the patient's out-of-pocket price.

50.8
30-Day Fills
standardized to 30-day supplies
1,524
Days of Medication
total across all patients in 2023

About Erythromycin: Erythromycin is used to treat a wide variety of bacterial infections. Show more ▾

It may also be used to prevent certain bacterial infections. Erythromycin is known as a macrolide antibiotic. It works by stopping the growth of bacteria. This antibiotic treats or prevents only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

In 2023, this provider wrote 26 Medicare prescriptions for Erythromycin, about half the volume of the typical Delaware prescriber of this medication (45). Medicare paid an average of $17.34 per fill, versus $12.31 statewide.

How often this provider prescribes it

This provider
26
DE average
45.0

This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$17.34
DE average
$12.31

Gross Part D cost per fill; not the patient's out-of-pocket price.

38.7
30-Day Fills
standardized to 30-day supplies
825
Days of Medication
total across all patients in 2023

About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾

Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor.

In 2023, this provider wrote 22 Medicare prescriptions for Timolol Maleate, about a third of the volume of the typical Delaware prescriber of this medication (64). Medicare paid an average of $25.75 per fill, versus $26.75 statewide.

How often this provider prescribes it

This provider
22
DE average
64.0

This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$25.75
DE average
$26.75

This provider's average cost per fill is below the DE average for this medication.

62.2
30-Day Fills
standardized to 30-day supplies
1,865
Days of Medication
total across all patients in 2023

About Travoprost: Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾

Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

In 2023, this provider wrote 17 Medicare prescriptions for Travoprost, about 68% of the volume of the typical Delaware prescriber of this medication (25). Medicare paid an average of $259.44 per fill, versus $276.88 statewide.

How often this provider prescribes it

This provider
17
DE average
25.0

This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$259.44
DE average
$276.88

This provider's average cost per fill is below the DE average for this medication.

36.6
30-Day Fills
standardized to 30-day supplies
1,097
Days of Medication
total across all patients in 2023

About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾

Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

In 2023, this provider wrote 15 Medicare prescriptions for Brimonidine Tartrate, about a quarter of the volume of the typical Delaware prescriber of this medication (56). Medicare paid an average of $34.31 per fill, versus $70.53 statewide.

How often this provider prescribes it

This provider
15
DE average
56.0

This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$34.31
DE average
$70.53

This provider's average cost per fill is below the DE average for this medication.

37.7
30-Day Fills
standardized to 30-day supplies
1,132
Days of Medication
total across all patients in 2023

About Tyrvaya: Varenicline is used by adults to help stop smoking. Show more ▾

To increase your chance of success, use this medication with a stop-smoking program that includes education, support, and counseling. Quitting smoking lowers your risk of heart and lung disease, as well as cancer. Varenicline works by blocking nicotine's effects in the brain that make you want to smoke. Discuss the risks and benefits of this medication, as well as other ways to quit smoking (such as nicotine replacement treatment), with your doctor. A benzazepine derivative that functions as an ALPHA4-BETA2 NICOTINIC RECEPTOR partial agonist. It is used for SMOKING CESSATION.

In 2023, this provider wrote 12 Medicare prescriptions for Tyrvaya, about half the volume of the typical Delaware prescriber of this medication (22). Medicare paid an average of $1,612.01 per fill, versus $694.00 statewide.

How often this provider prescribes it

This provider
12
DE average
22.0

This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$1,612.01
DE average
$694.00

Gross Part D cost per fill; not the patient's out-of-pocket price.

30
30-Day Fills
standardized to 30-day supplies
900
Days of Medication
total across all patients in 2023
No medications match the current filters.
= the 5 medications this provider prescribes most. More than typical Typical Less than typical= prescription volume vs the average DE prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the DE average cost per fill.

About this data. The prescription history for KAREN MICHELLE RUDO MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Ophthalmology prescribing approach at this Milford, DE practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among DE prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.